First-in-patient study of OTL78 for intraoperative fluorescence imaging of prostate-specific membrane antigen-positive prostate cancer: a single-arm, phase 2a, feasibility trial

Judith A. Stibbe(Leiden University Medical Center), Hilda A. de Barros(The Netherlands Cancer Institute), Daan G. J. Linders(Leiden University Medical Center), Shadhvi S. Bhairosingh(Leiden University Medical Center), Elise M. Bekers(The Netherlands Cancer Institute), Pim J. van Leeuwen(The Netherlands Cancer Institute), Philip S. Low(On Target Laboratories (United States)), Sumith A. Kularatne(On Target Laboratories (United States)), Alexander L. Vahrmeijer(Leiden University Medical Center), Jacobus Burggraaf(Centre for Human Drug Research), Henk G. van der Poel(Amsterdam University Medical Centers)
The Lancet Oncology
April 13, 2023
Cited by 54Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis